United States

Giving BRD treatments an additional day to work can maximize benefits

Giving BRD treatments an additional day to work can maximize benefits

August 11, 2010 — In any average day, producers identify and treat cattle for bovine respiratory disease (BRD). Traditional treatments often require that cattle be treated again in as little as three days — a schedule that hardly allows producers a break before they’re back to giving another dose.

“The traditional few days between treatments doesn’t take into account newer technology that can be effective with just one treatment or with longer intervals in between treatments,” says Lee Bob Harper, DVM, managing veterinarian with Pfizer Animal Health. “More days in between treatments makes economic sense for producers looking to maximize every investment.”

In a traditional BRD treatment pattern, producers administer an antibiotic and then re-treat those cattle still exhibiting BRD signs after about three days. This pattern doubles producers’ treatment expenses in product, labor and time with every re-treat. 

To get a better measure of a product’s value, Dr. Harper recommends producers evaluate treatments on a per-day cost of therapy. With a full course of BRD therapy in a single injection, investing in technology can pay off rapidly.

“Choosing treatments that can effectively treat BRD in a single dose and giving those products extra time to treat the disease can make a difference in the health of cattle and toward the bottom line,” Dr. Harper says.

For example, products like DRAXXIN® (tulathromycin), have been proven to be effective for seven to 14 days after the first treatment. In one study, 85 percent of cattle were treated successfully after a single injection with no difference in mortality rates or average daily gain following a seven, 10 or 14 day PTI.1

“Once you’ve invested in technology, whether equipment or antibiotics, it’s important to maximize the investment and give the products the chance to pay you back. Waiting even one more day before determining if a re-treat is needed can help producers do just that,” Dr. Harper says. “However, not all products have this level of effectiveness, and that’s why it’s important to work with your veterinarian to help make antibiotic selections carefully based on solid research instead of tradition.”
 
Do not use in calves to be processed for veal. A pre-slaughter withdrawal time has not been determined for pre-ruminating calves. Effects on reproductive performance, pregnancy and lactation have not been determined. DRAXXIN has a pre-slaughter withdrawal time of 18 days.
 
For more information, contact: 
Michelle Tollefson  
Pfizer Animal Health  
(212) 733-0502    
michelle.tollefson@pfizer.com 
 
Jennifer Ryan
Bader Rutter & Associates
(970) 689-3385
jryan@bader-rutter.com 
 
1Pfizer Animal Health Technical Bulletin. Efficacy of DRAXXIN, followed by 7-, 10-, or 14-day post-treatment intervals, against naturally occurring bovine respiratory disease. August 2006. Available at: http://www.draxxin.com/pdfs/draxxin/DRX06011_b.pdf. Accessed May 4, 2010.
 
All brands are the property of Pfizer Inc., its affiliates and/or its licensors. ©2010 Pfizer Inc. All rights reserved. LITCODENEEDED